ARMO BioSciences, Inc.

/ARMO BioSciences, Inc.

They are a late-stage immuno-oncology company that is developing a pipeline of novel, proprietary product candidates that activate the immune system of cancer patients to recognize and eradicate tumors.

Symbol

Price Range
TBD

Anticipated Shares
7,500,000

Effective Date
January 26, 2018

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange